The U.S. Food and Drug Administration (FDA) has granted fast-track designation to CK0803, an experimental T-cell therapy from Cellenkos that’s currently in Phase 1 clinical testing for people with ...
Researchers at MIT have found a way to use a nontoxic antifreeze sugar to protect CAR-T cells from damage during storage and ...
The immune system may learn not to attack the body by using a small but representative sample of the body’s own protein ...
CAR T-cell therapy has transformed cancer care, offering new hope to patients with aggressive blood cancers who once had few ...
Final phase 1 results showed lasting responses to soquelitinib in some patients with relapsed or refractory T cell lymphoma.
The authors compared the CD4+ T-cell counts and HIV-1 RNA viral loads of 383 patients who were either mono-infected with HIV or co-infected with HTLV-1/HIV. They confirmed that co-infected patients ...
By using mRNA molecules to “remodel” parts of the immune system, researchers generated T cells that can slow the growth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results